αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

NCT05373147 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: αPD1-MSLN-CAR T cells

Sponsor

Shanghai Mengchao Cancer Hospital

Collaborators

[object Object]